Research project

Combining structural biology with AI-guided protein design to develop new antibody-degrading enzymes.

Staff

Lead researchers

Professor Max Crispin DPhil, FRSB, FRSC, FHEA

Director (Institute for Life Sciences)
Research interests
  • Viral Glycobiology
  • Therapeutic Antibodies
Connect with Max

Other researchers

Professor Ivo Tews

Professor
Research interests
  • Cancer immunology, where a structure based approach to rational drug development is applied f…
  •  
  •  
Connect with Ivo

Dr Joel Allen

Principal Research Fellow
Research interests
  • Mass spectrometry
  • Viral glycobiology
  • Immunogen design
Connect with Joel

Research outputs